Our molecular biologists run our basic science and laboratory facilities, including molecular biological testing, DNA collection and genetic sequencing.
Dr. Carlquist has been involved in cardiovascular research since 1982. Early investigations examined cellular and immunological factors in idiopathic cardiomyopathy and the rejection of cardiac transplants. Later studies attempted to identify genetic factors that contribute to cardiomyopathy and coronary artery disease.
These early studies led to the founding of the Cardiovascular DNA bank, which Dr. Carlquist has directed since its establishment. The bank presently stores DNA and plasma samples from over 27,000 consenting patients.
In his role, Dr. Carlquist has served as principal or co-principal investigator on numerous federally and privately funded projects. He has also received two American Heart Association research awards and 12 internal research grants from the Intermountain Research and Medical Foundation, formerly the Deseret Foundation.
Dr. Carlquist has been a manuscript referee for 25 peer reviewed journals and currently serves on the editorial board for one publication. He also founded the Intermountain Healthcare Molecular Diagnostics Laboratory, served as the Laboratory Medical Director for several years and continues to serve as the Technical Director. He holds the academic rank of Professor (research track) in the Department of Internal Medicine, University of Utah School of Medicine.
Dr. Galenko’s research is focused on the genetic and cellular factors of cardiovascular disease. More specifically, she is examining the role of microRNAs and their potential use as a diagnostic tools or therapeutic targets in patients with cardiovascular disease. MicroRNAs are critical molecules in our cells that regulate gene expression in response to various physiological and pathological stimuli.